Related by context. Frequent words. (Click for all words.) 69 Panzem R 68 AA amyloidosis 67 secondary hyperparathyroidism 66 diabetic nephropathy 66 immuno inflammatory diseases 66 hypercholesterolemia 66 6R BH4 66 carcinoid syndrome 66 idiopathic pulmonary fibrosis IPF 66 hypoparathyroidism 66 inflammatory autoimmune 66 phenylketonuria PKU 65 Fibrillex TM 65 phase IIb clinical 65 rheumatoid arthritis multiple sclerosis 65 ALN TTR# 65 myelodysplastic syndrome MDS 65 hyperuricemia 65 Rheumatoid Arthritis RA 65 Zolinza 65 hepatitis C HCV 65 fibrotic diseases 65 SHPT 64 liposomal formulation 64 Epratuzumab 64 Mipomersen 64 cancer cachexia 64 metastatic castration resistant 64 Parkinson disease Alzheimer disease 64 dirucotide 64 MEK inhibitor 64 Diabetic Macular Edema 64 candidiasis 63 investigational compounds 63 constipation IBS C 63 systemic lupus erythematosus SLE 63 chemotherapy induced neutropenia 63 paroxysmal nocturnal hemoglobinuria 63 multiple sclerosis rheumatoid arthritis 63 Voreloxin 63 Phenoptin 63 gastrointestinal stromal tumors GIST 63 rheumatoid arthritis psoriasis 63 teplizumab 63 MKC# 63 FLT3 63 primary hypercholesterolemia 63 degenerative disorders 63 anticancer compound 63 hypoxia inducible factor 63 KNS # 63 Vandetanib 63 Cushing Syndrome 63 Pirfenidone 63 pheochromocytoma 63 osteoarthritis rheumatoid arthritis 63 metastatic hormone refractory 63 Phase IIa trial 63 pseudobulbar affect PBA 62 HCV protease inhibitor 62 rNAPc2 62 phenylketonuria 62 Stedivaze 62 diabetic neuropathic pain 62 cutaneous T cell 62 castration resistant prostate cancer 62 forodesine 62 Vascular Endothelial Growth 62 Onalta 62 diabetic macular edema DME 62 hematologic diseases 62 chronic HCV infection 62 ATL# [001] 62 Benign Prostatic Hyperplasia 62 luteinizing hormone releasing 62 pancreatic insufficiency 62 Phase 2b clinical trials 62 myeloid 62 mTOR inhibitor 62 multi kinase inhibitor 62 myeloproliferative disorders 62 geographic atrophy 62 Aerosurf 62 mixed dyslipidemia 62 CCX# 62 DDP# 61 Amphotericin B 61 liver fibrosis 61 superficial bladder cancer 61 humanized anti 61 systemic lupus erythematosus 61 familial hypercholesterolemia 61 selectively inhibit 61 immunological disorders 61 post herpetic neuralgia 61 hypercalcemia 61 opioid induced constipation 61 SGLT2 61 mRCC 61 Dasatinib 61 endocrine diseases